ARTICLE | Clinical News
NeisVac-C group C meningococcal conjugate vaccine regulatory update
January 22, 2002 8:00 AM UTC
Canada granted marketing approval to BAX for its NeisVac-C vaccine. BAX acquired the product through its 1999 purchase of North American Vaccine Inc. (Columbia, Md.), and Shire Pharmaceuticals Group ...